Search - tctmd.com

Displaying 1 - 12 of 12

Sort: Relevancy | Date

News Conference News TCT 2022

SYMPLICITY HTN-3’s Late Surprise: Sustained BP Drop at 3 Years Despite Earlier Miss

Michael O'Riordan

September 19, 2022

News Conference News TCT 2022

RADIANCE II Confirms Ultrasound-Based Renal Denervation Lowers BP

Todd Neale

September 18, 2022

News Conference News TCT 2021

Renal Denervation May Help Cut BP Meds, Sham-Controlled Trial Hints

Todd Neale

November 04, 2021

News Conference News TCT 2021

NSTEMI Patients With CKD See Better Outcomes With Invasive Strategy

L.A. McKeown

October 22, 2021

News Conference News TCT 2020

Treating Accessory Arteries May Be Important in Renal Denervation

Todd Neale

October 18, 2020

News Conference News TCT 2018

RADIOSOUND-HTN Suggests Ultrasound May Be Best for Renal Denervation

Todd Neale

September 26, 2018

News Conference News TCT 2018

Prematurely Halted Pilot Study Snaps Recent Winning Streak for Renal Denervation

Todd Neale

September 25, 2018

$Symplicity Flex: A Prospective, Randomized, Sham-Controlled Trial of Renal Sympathetic Denervation in Patients with Mild Refractory Hypertension$

Presentation TCT 2014

Symplicity Flex: A Prospective, Randomized, Sham-Controlled Trial of Renal Sympathetic Denervation in Patients with Mild Refractory Hypertension

Presenter: Ajay J. Kirtane, Deepak L. Bhatt, Steffen Desch

September 16, 2014

Presentation TCT 2013

Moving Away From Surrogate Measures: Rationale and Design for a Clinical Outcomes Trial of Renal Artery Denervation (EnligHTNment)

Presenter: Felix Mahfoud

October 27, 2013

Presentation TCT 2013

Is Urinary Neutrophil Gelatinase-Associated Lipocalin the “Renal Troponin” in Invasive Cardiology?

Presenter: Tilman Perrin, Eric Descombes, St?phanie Gobet, Jean-Luc Magnin, Magali Gachet, Ould Hemett, Daniel Hayoz, Val?rie Stolt, G?rard Baeriswyl, Jean-Christophe Stauffer, Jean-Jacques Goy, Mario Togni, St?phane Cook

January 31, 2013

Presentation TCT 2012

SYMPLICITY Results Are Too Good to Be True: That's Why We Need a Sham Trial Design!

Presenter: Darrel Francis

October 24, 2012

Presentation TCT 2012

DES for Vascular Erectile Dysfunction: Follow-up from the ZEN First-in-Man Study

Presenter: Krishna Rocha-Singh

October 22, 2012

Advertisement

SYMPLICITY HTN-3’s Late Surprise: Sustained BP Drop at 3 Years Despite Earlier Miss

RADIANCE II Confirms Ultrasound-Based Renal Denervation Lowers BP

Renal Denervation May Help Cut BP Meds, Sham-Controlled Trial Hints

NSTEMI Patients With CKD See Better Outcomes With Invasive Strategy

Treating Accessory Arteries May Be Important in Renal Denervation

RADIOSOUND-HTN Suggests Ultrasound May Be Best for Renal Denervation

Prematurely Halted Pilot Study Snaps Recent Winning Streak for Renal Denervation

Symplicity Flex: A Prospective, Randomized, Sham-Controlled Trial of Renal Sympathetic Denervation in Patients with Mild Refractory Hypertension

Moving Away From Surrogate Measures: Rationale and Design for a Clinical Outcomes Trial of Renal Artery Denervation (EnligHTNment)

Is Urinary Neutrophil Gelatinase-Associated Lipocalin the “Renal Troponin” in Invasive Cardiology?

SYMPLICITY Results Are Too Good to Be True: That's Why We Need a Sham Trial Design!

DES for Vascular Erectile Dysfunction: Follow-up from the ZEN First-in-Man Study

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content